Skip to main content
All lobbying filings

LUPIN PHARMACEUTICALS INC

Lobbying for LUPIN PHARMACEUTICALS INC

 Filing 1st Quarter - Report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 23, 2025
Income
$75,000.00
What the client paid this registrant for the period.
Client based in
Maryland

Official filing document

 Lobbyists on this filing 1
  • SHAWN BROWN ESQ
    Previously held: VP Government Affairs

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Lobbying activity 4
Health Issues

BLOCKING Act, Patent Thickets, Patent Settlements, Interchangeability of biosimilars, Q1Q2 transparency, PBM Reform, Inflation Reduction Act, Abbreviated Drug Labeling, Tariffs, Domestic Manufacturing, DSCSA.

Medicare/Medicaid

Reimbursement of generic pharmaceuticals and biosimilars.

Pharmacy

Country of Origin labeling.

Manufacturing

Incentivizing domestic manufacturing of essential medicines.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem